Top compounds associated with response to LGALS9B


Feature Type Standardized
Nominal ANOVA
mRNA rigosertib CTRPv2 pan-cancer AAC 0.02 0.6
mRNA spautin-1 CTRPv2 pan-cancer AAC -0.023 0.6
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC -0.046 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.021 0.6
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.6
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.02 0.6
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.02 0.6
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.02 0.6
mRNA PLX4720 CTRPv2 pan-cancer AAC -0.019 0.6
Download CSV